Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06645093
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-14
Brief Title:
Feasibility of Intermittent Fasting During Chemotherapy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Intermittent Fasting During Curatively Intended Chemotherapy for Malignant Lymphoma - a Randomized Feasibility Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Fastestudien
Brief Summary:
The goal of this randomized controlled parallel group trial is to examine if fasting before and after chemotherapy is safe feasible and acceptable The study population will include patients with either Hodgkin lymphoma or Diffuse Large B Cell Lymphoma
The main questions aimed to answer are
Whether fasting during chemotherapy is safe for patients whether it is feasible to implement in a clinical setting and whether patients find it acceptable
We also want to examine a number of patient-reported outcome measures regarding health status and quality of life such as dietary intake and adverse events from chemotherapy
Researchers will compare fasting to standard treatment
Participants will
Fast 24 hours before and 24 hours after chemotherapy in addition to standard treatment or receive only standard treatment
Keep a diary of their dietary intake 24 hours before and 24 hours after chemotherapy
Keep a diary of their dietary intake for three consecutive days between chemotherapy cycles
Answer questionnairesquestions in relation to side effects from fasting side effectsadverse events of chemotherapy quality of life
Take bioimpedance analysis including body mass index and body composition
Take blood- and feces samples
The main questions aimed to answer are
Whether fasting during chemotherapy is safe for patients whether it is feasible to implement in a clinical setting and whether patients find it acceptable
We also want to examine a number of patient-reported outcome measures regarding health status and quality of life such as dietary intake and adverse events from chemotherapy
Researchers will compare fasting to standard treatment
Participants will
Fast 24 hours before and 24 hours after chemotherapy in addition to standard treatment or receive only standard treatment
Keep a diary of their dietary intake 24 hours before and 24 hours after chemotherapy
Keep a diary of their dietary intake for three consecutive days between chemotherapy cycles
Answer questionnairesquestions in relation to side effects from fasting side effectsadverse events of chemotherapy quality of life
Take bioimpedance analysis including body mass index and body composition
Take blood- and feces samples
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None